Artificial intelligence, machine learning, and digitalization systems in the cell and gene therapy sector: a guidance document from the ISCT industry committees
Vincenzo Di Cerbo, Hannah W. Song, Laura Herbst et al. · Cytotherapy · 2025
Cited by 14 works. doi:10.1016/j.jcyt.2025.05.003
Authors
- Vincenzo Di Cerbo
- Hannah W. Song
- Laura Herbst
- Sean J. Hart
- Rukmini Ladi
- Shanya Jiang
- Abeer S. Madbouly
- Lydia Redmond
- Simone Stickland
- Anand Srinivasan
- Keara Trinkle
- Anthony E. Ting
- Shannon S. Eaker
- Dalip Sethi
References
- Chimeric Antigen Receptor Therapy
- A foundation model for generalizable disease detection from retinal images
- FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine
- CAR T-cell therapy in autoimmune diseases
- The state of cell and gene therapy in 2023
- New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology
- Trust in and Acceptance of Artificial Intelligence Applications in Medicine: Mixed Methods Study
- A Conceptual Model for Digital Shadows in Industry and Its Application
- Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer
- Toward Rapid, Widely Available Autologous CAR-T Cell Therapy – Artificial Intelligence and Automation Enabling the Smart Manufacturing Hospital